We are happy to introduce Axol Bioscience!
Axol Bioscience believes that having more human-relevant disease models will expand scientific knowledge and de-risk drug development. They use human iPSCs to achieve this and have been doing so for over a decade.
They take cells from patient and healthy donors and, using their leading iPSC technology, work with researchers to build physiologically relevant in vitro models. They have a special focus on neurodegenerative diseases, such as Alzheimer’s Disease, as well as cardiotoxicity to promote drug safety.
axoCells™
With over a decade of experience, Axol has developed the manufacturing capabilities to produce high-quality, functional iPSC-derived cells with excellent consistency. Your research can benefit from their quality-focused approach, with a catalog of iPSC-derived neurons, neuroinflammatory cells, muscle cells, and cardiomyocytes manufactured at their ISO 9001:2015-accredited production facility.
axoCells cell types:
- cortical excitatory neurons
- striatal neurons
- cortical inhibitory interneurons
- sensory neurons
- motor neurons
- neuroinflammatory cells (microglia and astrocytes)
- cardiac cells (atrial and ventricular cardiomyocytes)
- muscle cells (skeletal myotubes)
Key therapy areas include:
- Alzheimer's disease
- Parkinson's disease
- ALS
- Huntington's disease
- Friedreich's ataxia
- Frontotemporal dementia
Axol Bioscience 2024 Catalog
The Axol Bioscience 2024 catalog showcases a comprehensive range of iPSC-derived cells and advanced in vitro systems, highlighting key therapy areas such as neuroscience, pain/inflammation, and cardiovascular applications.
Focus on Alzheimer's Disease
The Axol Bioscience "Focus on Alzheimer’s Disease" flyer details their innovative use of iPSC technology to create high-quality, functional cell types, such as cortical excitatory neurons, to advance research and drug development for Alzheimer's Disease.
Modeling ALS with iPSC-Derived Cells
The "Modeling ALS with iPSC-Derived Cells" flyer from Axol Bioscience outlines their cutting-edge approach to using iPSC technology to develop physiologically relevant motor neuron models, aimed at enhancing the understanding and treatment of Amyotrophic Lateral Sclerosis.
Our product specialists
Let's Talk Science!
Our Product Specialists are scientists with many years of experience and are always up-to-date regarding new products and can guide you to the best solutions.
